Aviex Technologies LLC was founded
to develop a novel vaccine platform delivery technology for infectious diseases.

Technology Advantages


Aviex uses a novel vaccine platform delivery technology based on live attenuated Salmonella bacteria that have to date proven safe for use in humans or animals. The bacteria are engineered to express target antigens and deliver them to the intestinal mucosa, following oral and/or multi modality administration. In the intestines, the bacteria are able to persist for days to weeks, during which time they continuously produce antigens thereby leading to a potent immune response.


Live attenuated Salmonella-based Vaccines with Simple Production Scheme